Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
13.5M
-
Shares change
-
+2.99M
-
Total reported value, excl. options
-
$95M
-
Value change
-
+$21.1M
-
Number of buys
-
18
-
Number of sells
-
-6
-
Price
-
$7.01
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2022
31 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.5M shares
of 44.5M outstanding shares and own 30.39% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (3.57M shares), ORBIMED ADVISORS LLC (3.03M shares), Opaleye Management Inc. (1.64M shares), RTW INVESTMENTS, LP (1.02M shares), Industry Ventures, L.L.C. (580K shares), PURA VIDA INVESTMENTS, LLC (556K shares), Velan Capital Investment Management LP (498K shares), VANGUARD GROUP INC (392K shares), Pentwater Capital Management LP (390K shares), and AIGH Capital Management LLC (306K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.